← back to search

Aurélien Dinh

Centre Hospitalier de Versailles · FR
Area of research
Surgery · Epidemiology
Research interest
Research interests include Urinary Tract Infections Management, Orthopedic Infections and Treatments, Antibiotic Resistance in Bacteria, and Antibiotic Use and Resistance.
h-index
37
citations
5,206
works
437
NIH funding
primary concept
Medicine
email

Recent publications

Role of Cefiderocol in the Treatment of Carbapenem-Resistant Nonfermenting Gram-Negative Bacilli (Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia) Infections: An Expert Statement.
2026cited by 0position: contributordoi
Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections.
2026cited by 0position: contributordoi
Assessment of Infectious Risk Factors in Benign Prostatic Hyperplasia Surgery: Results of the French Multicenter TOCUS Study.
2026cited by 0position: contributordoi
Delay and factors associated with early clinical stability during community-acquired pneumonia: A case control study
International Journal of Infectious Diseases 2026cited by 0position: contributordoi
Antibiotic tolerance and safety in infective endocarditis: A focus on older patients
Infectious Diseases Now 2026cited by 0position: contributordoi
Temocillin for non-urinary tract infections caused by AmpC-producing Enterobacterales: Is it a feasible option?
Infectious Diseases Now 2026cited by 0position: contributordoi
Diagnostic value of echocardiography for infective endocarditis in older adults.
2026cited by 0position: contributordoi
Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.
2025cited by 15position: contributordoi
Artificial intelligence and infectious diseases: Scope and perspectives
Infectious Diseases Now 2025cited by 6position: contributordoi
Suppressive Antibiotic Therapy in Prosthetic Joint Infections: A Contemporary Overview.
2025cited by 4position: contributordoi
The latest updates on the proper use of fluoroquinolones - Actualisation 2025 update by the SPILF and the GPIP.
2025cited by 2position: contributordoi
Cutaneous infections with Corynebacterium diphtheriae in France: A cohort study
Infectious Diseases Now 2025cited by 1position: contributordoi
Value of molecular biology tests in community-acquired acute pneumonia
Infectious Diseases Now 2025cited by 1position: contributordoi
Lung ultrasonography for community-acquired pneumonia diagnosis
Infectious Diseases Now 2025cited by 1position: contributordoi
Weekly Oral Cycling Antibiotic Treatment: A New Antibioprophylaxis Regimen for Recurrent Urinary Tract Infections.
2025cited by 0position: contributordoi
Treatment Duration in Bacterial Prosthetic Joint Infections: A Narrative Review of Current Evidence.
2025cited by 0position: contributordoi
Prosthetic Joint Infections: A Systematic Review
2025cited by 0position: contributordoi
Suppressive Antibiotic Therapy in Prosthetic Joint Infections: A Contemporary Overview
2025cited by 0position: contributordoi
In Vitro Evaluation of Fosfomycin Combinations Against Metallo-β-Lactamase-Producing <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i> Clinical Isolates.
2025cited by 0position: contributordoi
Actualisation des recommandations de prise en charge des pneumonies aiguës communautaires chez l'adulte par la Société de Pathologie Infectieuse de Langue Française (SPILF) et la Société de Pneumologie de Langue Française (SPLF). Avec le soutien de la Société de Réanimation de Langue Française, (SRLF), de la Société Française de Microbiologie (SFM), de la Société Française de Radiologie (SFR) et de la Société Française de Médecine d'Urgence (SFMU)
Médecine et Maladies Infectieuses Formation 2025cited by 0position: contributordoi
Antibiotic combination indications for the treatment of community-acquired acute pneumonia
Infectious Diseases Now 2025cited by 0position: contributordoi
Duration of antibiotic treatment for community-acquired pneumonia.
2025cited by 0position: contributordoi
Indications for corticosteroids in the treatment of Community-Acquired pneumonia
Infectious Diseases Now 2025cited by 0position: contributordoi
Towards more personalized management of pneumonia: recent progress and outstanding issues
Infectious Diseases Now 2025cited by 0position: contributordoi
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial
The Lancet Infectious Diseases 2024cited by 76position: middledoi
What Place Is There for Long-Acting Antibiotics in the Management of Gram-Positive Infections? A Qualitative Cross-Sectional Study.
2024cited by 1position: contributordoi
National Cohort of Compassionate Use of Meropenem-Vaborbactam: No Benefit over Meropenem for <i>Pseudomonas aeruginosa</i>.
2024cited by 1position: contributordoi
Real-life impact on antimicrobial prescription of Syndromic Molecular Testing in adults hospitalized in infectious disease departments. Respiratory Syndromic Molecular Testing panel: Is it worth it?
Infectious Diseases Now 2024cited by 0position: contributordoi
Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcome.
2023cited by 2position: contributordoi
Real-life impact of respiratory panel PCR assay on antibiotic prescription in geriatric acute care in the pre-COVID-19 era
Infectious Diseases Now 2023cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 45 papers (2019–2026)François-Xavier Lescure · Inserm10 papers (2017–2020) · 6 papers (2020–2020)Damien Basille · BMJ Publishing Group4 papers (2025–2025)Simon Galmiche · Ecole Pasteur Cnam de Santé publique4 papers (2020–2020) · 4 papers (2020–2020) · 4 papers (2020–2020)Patrick Jourdain · Université Paris-Saclay4 papers (2020–2023)Arnaud Fontanet · 4 papers (2020–2020)Youri Yordanov · BMJ Publishing Group4 papers (2020–2023)Agnès Dechartres · Elsevier, Inc.4 papers (2020–2023)Louis Bernard · Institut Cochin3 papers (2017–2021)Arnaud Scherpereel · Recherche translationnelle sur le diabète3 papers (2020–2020)B. Davido · BMJ Publishing Group3 papers (2019–2020)Simon Galmiche · Institut Pasteur2 papers (2020–2020)Àlex Soriano · Instituto de Salud Carlos III2 papers (2019–2026)Fabrice Denis · European Automobile Manufacturers Association2 papers (2020–2020)François Bénézit · Hôpital Pontchaillou2 papers (2020–2020)Adrien Lemaignen · Université de Tours2 papers (2017–2019)Arnaud Fontanet · Institut Pasteur2 papers (2020–2020)